The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2024

Filed:

Mar. 06, 2023
Applicant:

Pharmala Biotech Inc., Vancouver, CA;

Inventors:

Nicholas Kadysh, Vancouver, CA;

Leonard Howell, Atlanta, GA (US);

Harpreet Kaur, Nanaimo, CA;

Assignee:

PHARMALA BIOTECH INC., Vancouver, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/357 (2006.01); A61P 25/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/357 (2013.01); A61P 25/00 (2018.01);
Abstract

The present application includes a composition comprising a non-racemic mixture a compound of Formula (R)-I, or a salt and/or solvate thereof, and (S)-I, or a salt and/or solvate thereof: wherein (R)-I, or a salt and/or solvate thereof, is present in the composition in a greater amount by enantiomeric equivalents, relative to (S)-I, or a salt and/or solvate thereof. Also included are methods of using these compositions for treating, for example, a psychiatric disorder. The compounds of Formula (R)-I and (S)-I include the enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and N-methyl-1,3-benzodioxolylbutanamine (MBDB). Also included in the present application is a method for treating various diseases, disorders or conditions using a therapeutically effective amount of (R)-MDMA, or a pharmaceutically acceptable salt and/or solvate thereof.


Find Patent Forward Citations

Loading…